Posterior Reversible Encephalopathy Syndrome on 18F-FDG PET/CT in a Pediatric Patient With Burkitt's Lymphoma

Clin Nucl Med. 2018 Mar;43(3):195-198. doi: 10.1097/RLU.0000000000001979.

Abstract

We present a case of posterior reversible encephalopathy syndrome (PRES) in a pediatric patient with Burkitt's lymphoma predominantly involving the bone marrow. F-FDG PET/CT scan obtained after the first cycle of chemotherapy, complicated by acute kidney injury, hypertension, tumor lysis syndrome, and lethargy with focal neurological symptoms, showed a favorable marrow and lymph node response but increased FDG uptake in the bilateral frontal and occipital cortical/subcortical regions. Brain MRI was consistent with PRES. The patient was managed with IV hydration and blood pressure control with symptom resolution. This case shows the F-FDG uptake pattern of PRES in postchemotherapy setting.

Publication types

  • Case Reports

MeSH terms

  • Biological Transport
  • Burkitt Lymphoma / complications*
  • Burkitt Lymphoma / drug therapy
  • Child
  • Female
  • Fluorodeoxyglucose F18* / metabolism
  • Humans
  • Positron Emission Tomography Computed Tomography*
  • Posterior Leukoencephalopathy Syndrome / complications*
  • Posterior Leukoencephalopathy Syndrome / diagnostic imaging*
  • Posterior Leukoencephalopathy Syndrome / metabolism

Substances

  • Fluorodeoxyglucose F18